Storage Meets AI: Longsys to Showcase Comprehensive Innovation at COMPUTEX 2025

Storage Meets AI: Longsys to Showcase Comprehensive Innovation at COMPUTEX 2025

SHENZHEN, China, May 12, 2025 /PRNewswire/ -- Longsys(301308.SZ), a branded semiconductor enterprise, will exhibit at COMPUTEX 2025 from May 20 to 23 at the Taipei Nangang Exhibition Center, under the theme "Storage Meets AI." As artificial...

Nick Offerman and Megan Mullally Bring Unscripted and Unfiltered Chaos to Vivid Sydney

Nick Offerman and Megan Mullally Bring Unscripted and Unfiltered Chaos to Vivid Sydney

SYDNEY, May 8, 2025 /PRNewswire/ -- Television icons Nick Offerman and Megan Mullally will appear on stage together for the first time in Australia at Vivid Sydney 2025, the Southern Hemisphere's largest arts and culture festival. Unscripted and...

Gamma Communications Recognized with Frost & Sullivan's 2024 European UCaaS Competitive Strategy Leadership Award

Gamma Communications Recognized with Frost & Sullivan's 2024 European UCaaS Competitive Strategy Leadership Award

The company has shown exceptional strategy execution, innovation, and customer-centric growth in a rapidly evolving market. SAN ANTONIO, Texas, May 6, 2025 /PRNewswire/ -- Frost & Sullivan is proud to present Gamma Communications with the 2024...

HVL Hotels: Redefining Luxury in the Heart of the Hunter Valley

HVL Hotels: Redefining Luxury in the Heart of the Hunter Valley

SYDNEY, April 30, 2025 /PRNewswire/ -- HVL Hotels in conjunction with Figure 8 capital is proud to present a visionary luxury hospitality project poised to redefine the Hunter Valley experience. This ultra-premium destination reimagines what a...

Avnet AI Tech Days Empower Singapore's AI Ambitions

Avnet AI Tech Days Empower Singapore's AI Ambitions

Event in Singapore to Showcase Latest AI Solutions and Expertise, Supporting National Growth Goals SINGAPORE, April 29, 2025 /PRNewswire/ -- Building on Singapore's growing leadership in artificial intelligence (AI), fueled by strategic initiatives...

Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025

Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025

SHANGHAI, April 29, 2025 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies for cancer, today...

Invitation to Minesto's Webinar: Interim Management Statement Q1 2025

Invitation to Minesto's Webinar: Interim Management Statement Q1 2025

GOTHENBURG, Sweden, April 28, 2025 /PRNewswire/ -- On April 30, Minesto, leading ocean energy developer, will publish their Interim Management Statement 1 January - 31 March 2025. Dr Martin Edlund, CEO, and Gustav Kvibling, CFO, will present details...

Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)

Celltrion to present six abstracts in inflammatory bowel disease (IBD) at 2025 Digestive Disease Week® (DDW)

Six abstracts accepted for presentation includes post hoc analyses and real-world evidence for ZYMFENTRA ® (infliximab-dyyb) Findings reinforce clinical decision-making in long-term management of moderate-to-severe Crohn's disease and ulcerative...

Fibocom Unleashes the Intelligent Power of AIoT in Korea at WIS 2025

Fibocom Unleashes the Intelligent Power of AIoT in Korea at WIS 2025

SEOUL, South Korea, April 24, 2025 /PRNewswire/ -- Fibocom, a global leading provider of wireless communication modules and AI solutions, showcases its latest innovative AIoT solutions at World IT Show 2025, held at COEX, Seoul. Fibocom demonstrates...

Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage

Sun Pharma and Moebius Medical Announce Dual Publications on MM-II's Phase 2b Clinical Trial Results and Mechanism of Action in Osteoarthritis and Cartilage

- Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA models featured in two peer-reviewed articles - - New data on MM-II to be presented this weekend at the OARSI 2025 World Conference on Osteoarthritis - -...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • menu
    menu